Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Tufano et al., Cells, 2021, 10, 2366. https://doi.org/10.3390/cells10092366 | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | P. D’Arrigo et al., Oncotarget, 2017, 8 (40): 68291-68304 | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
TM-GBM |
Human Glioma spheroides obtained by microdissection of U87MG xenografted mice brain | Human | brain | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
TM-GBM |
Human Glioma spheroides obtained by microdissection of U87MG xenografted mice brain | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
SVZ-GBM |
Human Glioma spheroides obtained by microdissection of U87MG xenografted mice brain | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
SVZ-GBM |
Human Glioma spheroides obtained by microdissection of U87MG xenografted mice brain | Human | brain | cell line | adherent | siRNA | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | |||
SVI |
Murine kidney podocyte cell line | Mouse | urinary system | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | F. Kliewe et al., FASEB J., 14460: 33, doi: 10.1096/fj.201900978RR | Link | ||
SVI |
Murine kidney podocyte cell line | Murine | urinary system | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
SKOV-3 |
Human epithelial ovarian adenocarcinoma cell line | ATCC HTB-77 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
||
SKOV-3 |
Human epithelial ovarian adenocarcinoma cell line | ATCC HTB-77 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Tufano et al., Front. Cell Dev. Biol., 2021, 9: 718947, doi: 10.3389/fcell.2021.718947 | Link | ||
rPASMC |
Rat pulmonary artery smooth muscle cells | Rat | respiratory system | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | J. Chen et al., Physiol Rep., 2017, 5 (18), e13441, https://doi.org/10.14814/phy2.13441 | Link | ||
rMSC |
Rat mesenchymal stem cells | Rat | unknown | stem cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | J. Park et al., Tissue Engineering: Part C, 2016, 22 (8): 809, DOI: 10.1089/ten.tec.2016.0182 | Link | ||
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | E. A. Ostrakhovitch et al., Exp. Cell Res., 2019, 385: 111683, doi.org/10.1016/j.yexcr.2019.111683 | Link | ||
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | E. A. Ostrakhovitch et al., PLoS ONE, 2020, 15(11): e0241685, doi.org/10.1371/journal.pone.0241685 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | B. Ljepoja, Dissertation, 2019, Ludwig-Maximilians-Universität München | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | B. Ljepoja et al., PLoS ONE, 2019, 14(11): e0224314, doi.org/10.1371/journal.pone.0224314 | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | H. Lutz, Dissertation, 2019, Technische Universität Darmstadt | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | H. Lutz et al., Cancers, 2019, 11: 306, doi:10.3390/cancers11030306 | Link | |
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | H. Huang et al., Scientific Reports, 2019; 9: 4954, doi: 10.1038/s41598-019-40848-4 | Link |